牛牛AI助理已提取核心訊息
In a recent transaction, Eric Floyd, associated with Virpax Pharmaceuticals Inc. [VRPX], executed a stock transaction on January 29, 2024. The specific details regarding the nature of the transaction, such as the action type, number of shares, transaction price, and the total value of shares, were not disclosed in the announcement. The relationship of Eric Floyd to the issuer was also not specified. Investors are advised to seek additional information to fully understand the implications of this transaction on their investment decisions.
In a recent transaction, Eric Floyd, associated with Virpax Pharmaceuticals Inc. [VRPX], executed a stock transaction on January 29, 2024. The specific details regarding the nature of the transaction, such as the action type, number of shares, transaction price, and the total value of shares, were not disclosed in the announcement. The relationship of Eric Floyd to the issuer was also not specified. Investors are advised to seek additional information to fully understand the implications of this transaction on their investment decisions.
在最近的一筆交易中，與Virpax Pharmicals Inc. [VRPX] 相關的埃裏克·弗洛伊德於2024年1月29日執行了一筆股票交易。公告中沒有披露有關交易性質的具體細節，例如行動類型、股票數量、交易價格和股票總價值。埃裏克·弗洛伊德與發行人的關係也沒有具體說明。建議投資者尋求更多信息，以充分了解該交易對其投資決策的影響。
在最近的一筆交易中，與Virpax Pharmicals Inc. [VRPX] 相關的埃裏克·弗洛伊德於2024年1月29日執行了一筆股票交易。公告中沒有披露有關交易性質的具體細節，例如行動類型、股票數量、交易價格和股票總價值。埃裏克·弗洛伊德與發行人的關係也沒有具體說明。建議投資者尋求更多信息，以充分了解該交易對其投資決策的影響。
有用
沒用
